{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"3"}],"title":"Subjects with infection"},{"measurements":[{"groupId":"OG000","value":"81"},{"groupId":"OG001","value":"36"}],"title":"Subjects without infection"}],"denoms":[{"counts":[{"groupId":"OG000","value":"83"},{"groupId":"OG001","value":"39"}],"units":"Participants"}],"title":"Cycle 1"},{"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"2"}],"title":"Subjects with infection"},{"measurements":[{"groupId":"OG000","value":"82"},{"groupId":"OG001","value":"36"}],"title":"Subjects without infection"}],"denoms":[{"counts":[{"groupId":"OG000","value":"83"},{"groupId":"OG001","value":"38"}],"units":"Participants"}],"title":"Cycle 2"},{"categories":[{"measurements":[{"groupId":"OG000","value":"5"},{"groupId":"OG001","value":"3"}],"title":"Subjects with infection"},{"measurements":[{"groupId":"OG000","value":"77"},{"groupId":"OG001","value":"34"}],"title":"Subjects without infection"}],"denoms":[{"counts":[{"groupId":"OG000","value":"82"},{"groupId":"OG001","value":"37"}],"units":"Participants"}],"title":"Cycle 3"},{"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"}],"title":"Subjects with infection"},{"measurements":[{"groupId":"OG000","value":"81"},{"groupId":"OG001","value":"37"}],"title":"Subjects without infection"}],"denoms":[{"counts":[{"groupId":"OG000","value":"82"},{"groupId":"OG001","value":"37"}],"units":"Participants"}],"title":"Cycle 4"},{"categories":[{"measurements":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"}],"title":"Subjects with infection"},{"measurements":[{"groupId":"OG000","value":"74"},{"groupId":"OG001","value":"31"}],"title":"Subjects without infection"}],"denoms":[{"counts":[{"groupId":"OG000","value":"83"},{"groupId":"OG001","value":"39"}],"units":"Participants"}],"title":"All cycles"}],"denoms":[{"counts":[{"groupId":"OG000","value":"83"},{"groupId":"OG001","value":"39"}],"units":"Participants"}],"description":"The number of subjects with infections for each arm of the study will be recorded for each and all 4 chemotherapy cycles.","groups":[{"description":"F-627, 20 mg fixed dose pre-filled syringe, dosed Day 2 of each of 4 chemotherapy cycles.","id":"OG000","title":"F-627"},{"description":"Placebo, pre-filled syringe administered Day 2 of the first chemotherapy cycle; and F-627, 20 mg fixed dose pre-filled syringe administered Day 2 of each of the following 3 chemotherapy cycles.","id":"OG001","title":"Placebo"}],"paramType":"COUNT_OF_PARTICIPANTS","populationDescription":"Some subjects terminated earlier","reportingStatus":"POSTED","timeFrame":"4 chemotherapy cycles, about 12 weeks","title":"Number of Participants With Infections for Each Chemotherapy Cycle and Over All Cycles.","type":"SECONDARY","unitOfMeasure":"Participants"}